Evidence map›Paper›PMID 38265386›Full record

ReviewCentral nervous system agents in medicinal chemistry2024

Exploring the Therapeutic Potential of Phytoconstituents for Addressing Neurodegenerative Disorders.

Sweta Kamboj, Prerna Sharma, Rohit Kamboj, Shikha Kamboj, Hariom, Girija, Kumar Guarve, Rohit Dutt, Inderjeet Verma, Kamal Dua and 1 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Central nervous system agents in medicinal chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sweta KambojGuru Gobind Singh College of Pharmacy, Yamuna Nagar, India.
Prerna SharmaGuru Gobind Singh College of Pharmacy, Yamuna Nagar, India.
Rohit KambojGuru Gobind Singh College of Pharmacy, Yamuna Nagar, India.
Shikha KambojGuru Gobind Singh College of Pharmacy, Yamuna Nagar, India.
HariomGuru Gobind Singh College of Pharmacy, Yamuna Nagar, India.
GirijaGuru Gobind Singh College of Pharmacy, Yamuna Nagar, India.
Kumar GuarveGuru Gobind Singh College of Pharmacy, Yamuna Nagar, India.
Rohit DuttGandhi Memorial National College, Ambala, India.
Inderjeet VermaMM College of Pharmacy, MM (Deemed to be University), Mullana, Ambala, India.
Kamal DuaDiscipline of Pharmacy Graduate of Technology, Sydney, Australia.
Nidhi RaniChitkara College of Pharmacy, Chitkara University, Chandigarh, Punjab, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neurodegenerative disorder is a serious condition that is caused by abnormal or no neurological function. Neurodegenerative disease is a major growing cause of mortality and morbidity worldwide, especially in the elderly. After World War Ⅱ, eugenics term was exterminated from medicines. Neurodegenerative disease is a genetically inherited disease. Lifestyle changes, environmental factors, and genetic modification, together or alone, are involved in the occurrence of this disorder. The major examples of neurodegenerative disorders are Alzheimer's and Parkinson's disease, in which apoptosis and necrosis are the two major death pathways for neurons. It has been determined from various studies that the etiology of the neurodegenerative disease involves the role of oxidative stress and anti-oxidant defence system, which are prime factors associated with the activation of signal transduction pathway that is responsible for the formation of synuclein in the brain and manifestation of toxic reactions in the form of functional abnormality, which ultimately leads to the dysfunction of neuronal pathway or cell. There has not been much success in the discovery of effective therapy to treat neurodegenerative diseases because the main cause of abnormal functioning or death of neurons is not well known. However, the use of natural products that are derived from plants has effective therapeutic potential against neurodegenerative disease. The natural compounds with medicinal properties to prevent neurological dysfunction are curcumin, wolfberry, ginseng, and Withania somnifera. The selection and use of natural compounds are based on their strong anti-inflammatory and anti-oxidant properties against neurodegenerative disease. Herbal products have active constituents that play an important role in the prevention of communication errors between neurons and neurotransmitters and their respective receptors in the brain, which influence their function. Considering this, natural products have great potential against neurodegenerative diseases. This article reviews the natural compounds used to treat neurodegenerative diseases and their mechanisms of action.

Indexed as

Neurodegenerative DiseasesPhytochemicalsAnimalsBiological ProductsHumansNeuroprotective AgentsBiological ProductsNeuroprotective AgentsPhytochemicalsgeneticnatural productNeurodegenerative diseases (NGDs)neurological dysfunctionneuroprotective.patientplants

Identifiers

PMID38265386

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.